Funder: National Institutes of Health (NIH)
Due Dates: October 16, 2024 | November 16, 2024 | March 16, 2025 | May 16, 2025
Funding Amounts: Up to $275,000 total direct costs over 2 years, with no more than $200,000 in any single year.
Summary: Supports exploratory basic research to elucidate how the human microbiome modulates anti-tumor immune responses and to identify novel molecular targets for cancer prevention.
Key Information: Clinical trials are not allowed; applications must rigorously address concentration, timing, and duration of administered microbes; foreign institutions are eligible to apply.